Médecins pour Cancer du larynx à l'étranger — Page 3

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Le Dr Auala Hubert est un oncologue médical et radiothérapeute au centre médical Hadassah, fort de 33 ans d'expérience spécialisée.

• Être titulaire d'une double certification en oncologie et en radiothérapie
• Diriger le centre de cancérologie gastro-intestinale
• Être membre de la Société israélienne d'oncologie clinique
• Obtenir un doctorat en médecine de la prestigieuse université Hadassah de Jérusalem

Le professeur associé Nail Paksoy apporte une vaste expertise en oncologie à l'hôpital Medipol Bahçelievler, avec une spécialisation dans le traitement du cancer du larynx.

• Certifié par l'ESMO en oncologie médicale
• Participation à 8 essais cliniques internationaux en tant que sous-investigateur
• Publication de plusieurs études sur les résultats des traitements contre le cancer
• Formation spécialisée à l'Institut d'oncologie de l'Université d'Istanbul

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Le Dr Karatas apporte une vaste formation internationale en oto-rhino-laryngologie et en chirurgie de la tête et du cou, avec des spécialisations effectuées à travers l'Europe et les États-Unis.

• Formation dans des institutions prestigieuses telles que l'école de médecine de Hanovre et l'université d'État de l'Ohio
• Membre de plusieurs sociétés professionnelles, dont l'American Academy of Otolaryngology
• Spécialisation dans les techniques chirurgicales avancées pour les cancers de la tête et du cou
• Travail à l'hôpital universitaire Atlas avec une concentration sur les cas complexes

Le professeur Ziv Gil dirige l'ensemble du département d'oto-rhino-laryngologie et de chirurgie cervico-faciale du célèbre centre médical Rambam en Israël.

• Chirurgien expérimenté spécialisé dans les cancers complexes de la tête et du cou
• Titulaire du prestigieux titre académique de professeur
• Expert dans la prise en charge des cas avancés de cancer du larynx
• Directeur d'un important département d'hôpital universitaire avec des équipes de spécialistes complètes

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Le professeur Young Ik Son se spécialise exclusivement en oncologie ORL au Samsung Medical Center.

• Professeur d'oto-rhino-laryngologie spécialisé dans le cancer du larynx
• Affilié au Samsung Medical Center – un hôpital de premier plan en Corée du Sud
• Vaste expérience dans le traitement des cas laryngés complexes

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Thomas Shpitzer est un oto-rhino-laryngologiste au centre médical Assuta, spécialisé dans les pathologies de la tête et du cou.

• Se concentrer sur les cas d'oncologie en oto-rhino-laryngologie
• Traiter les cancers de la gorge et du larynx
• Faire partie d'une équipe spécialisée dans un grand hôpital privé

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Le Prof. Dr Ismet Aslan est spécialisé dans les cancers de la tête et du cou, avec une vaste expérience de recherche et de pratique dans le traitement du cancer du larynx.

• Membre de l'Association turque de laryngologie et d'autres groupes professionnels d'ORL
• Publication de plus de 10 articles de recherche internationaux sur les pathologies ORL
• Plus de 30 ans d'expérience médicale dans le domaine de l'ORL
• Formation avancée suivie à l'Université d'Istanbul

Le Dr Topcu apporte son expertise internationale du MD Anderson et du Sunnybrook Odette Cancer Center au traitement du cancer du larynx à l'hôpital universitaire Biruni.

• Se spécialiser dans les cancers de la tête et du cou, y compris le cancer du larynx
• Être formé dans les meilleures institutions aux États-Unis et au Canada
• Être membre de l'ESMO et de l'ASCO – principales sociétés d'oncologie
• Avoir plus de 15 ans d'expérience en oncologie médicale

Le Dr Sahibov apporte une expérience spécialisée en radio-oncologie de l'Université de Marmara, où il a suivi une formation approfondie dans ce domaine.

• Formation spécialisée complétée à la Faculté de Médecine de l'Université de Marmara
• Maîtrise de l'anglais, facilitant une communication claire
• Travaille à l'Hôpital Emsey, reconnu pour ses soins oncologiques de pointe